Table 3

- Anti-coagulation type used to treat confirmed cases of coronavirus associated venous thromboembolism.

Author name	Age/Gender	Type of anticoagulant			Outcome	Complications
Author name	Age/Gender	Prior to VTE	VTE treatment (during hospitalization)	Upon discharge	Outcome	Complications
Kenyani Davis	34 M	N/A	N/A	NOAC	Recovery or discharge	N/A
Aoi et al	70 F	Heparin	IV Heparin	N/A	Death	Cardiac arrest
Brüggemann et al	57 M	LMWH (nadroparin)	LMWH (tinzaparin)	N/A	Recovery or discharge	Ischemic stroke
Colombo et al	73 F	LMWH (enoxaparin)	LMWH (enoxaparin)	NOAC	Recovery or discharge	Obstructive shock
Delcros et al	31 M	LMWH (enoxaparin)	LMWH (enoxaparin)	LMWH (enoxaparin)	Recovery or discharge	N/A
Fiorini et al	26 F	N/A	LMWH (enoxaparin)	NOAC	Recovery or discharge	N/A
Haider et al	46 F	Heparin	LMWH (enoxaparin)	NOAC	Recovery or discharge	N/A
Kasinathan et al	20 F	N/A	LMWH (enoxaparin)	LMWH (enoxaparin)	Recovery or discharge	N/A
Mene-Afejuku et al	67 M	Heparin	NOAC	NOAC	Recovery or discharge	N/A
	58 F	Heparin	LMWH (enoxaparin)	NOAC	Recovery or discharge	N/A
	89 F	Heparin	IV Heparin	NOAC	Recovery or discharge	N/A
	82 F	LMWH (enoxaparin)	LMWH (enoxaparin)	NOAC	Recovery or discharge	N/A
Akel et al	28 F	LMWH (enoxaparin)	tPA, LMWH (enoxaparin)	NOAC	Recovery or discharge	N/A
	52 M	LMWH (enoxaparin)	LMWH (enoxaparin)	NOAC	Recovery or discharge	N/A
	62 M	N/A	tPA, IV heparin	NOAC	Recovery or discharge	N/A
	49 M	LMWH (enoxaparin)	LMWH (enoxaparin)	NOAC	Recovery or discharge	N/A
	59 F	LMWH (enoxaparin)	LMWH (enoxaparin)	NOAC	Recovery or discharge	N/A
	69 M	Heparin	IV Heparin	NOAC	Recovery or discharge	N/A
Fortuzi et al	52 M	Heparin	IV Heparin	N/A	Death	AKI, Septic shock
	74 F	LMWH (enoxaparin)	LMWH (enoxaparin)	NOAC	Recovery or discharge	N/A
	31 M	N/A	NOAC	NOAC	Recovery or discharge	N/A
Kanso et la	68 M	LMWH (enoxaparin)	LMWH (enoxaparin)	Warfarin	Recovery or discharge	N/A
Kanso et la	62 M	LMWH (enoxaparin)	LMWH (enoxaparin)	NOAC	Recovery or discharge	N/A
Lewis et al	77 M	NOAC (Apixaban)	LMWH (enoxaparin)	N/A	Death	Multi-system organ failure
	70 M	NOAC (Apixaban)	LMWH (enoxaparin)	NOAC (Apixaban), LMWH (enoxaparin), loaded warfarin	Recovery or discharge	N/A
	76 M	NOAC (Rivaroxaban)	LMWH (enoxaparin)	NOAC (Rivaroxaban)	Recovery or discharge	N/A
	80 M	NOAC (Rivaroxaban)	LMWH (enoxaparin)	LMWH (enoxaparin)	Death	N/A
	92 M	NOAC (Apixaban)	Care withdrawn	Care withdrawn	Death	Left-sided facial droop, left-sided hemiplegia and stroke
Manek et al	66 M	N/A	IV heparin	NOAC (Apixaban)	Recovery or discharge	N/A
Mangala et al	55 M	LMWH (enoxaparin)	LMWH (enoxaparin)	NOAC (Apixaban)	Recovery or discharge	aspiration pneumonia
Mangala et al	67 F	LMWH (enoxaparin)	IV heparin	NOAC (Apixaban)	Recovery or discharge	N//A
Nelson et al	61 M	N/A	IV heparin	N/A	Death	Septic shock
Nelson et al	54 M	N/A	tPA, LMWH (enoxaparin)	N/A	Death	N/A.
Overstada et al	55 M	N/A	NOAC (Apixaban)	N/A	Recovery or discharge	N/A
	39 M	N/A	NOAC (Apixaban)	NOAC (Apixaban)	Recovery or discharge	N/A
	57 M	N/A	NOAC (Apixaban)	NOAC (Apixaban)	Recovery or discharge	N/A
	55 M	N/A	LMWH (Dalteparin)	LMWH (Dalteparin)	Recovery or discharge	N/A
Sakr et al	66 M	N/A	tPA and IV heparin	N/A	Death	Progressive multi-organ failure
	65 M	N/A	LMWH (enoxaparin)	LMWH	Recovery or discharge	N/A
	56 M	N/A	LMWH (enoxaparin)	LMWH	Recovery or discharge	N/A
	41 M	N/A	tPA, VA -ECMO, LMWH (tinzaparine)	LMWH	Recovery or discharge	Ventilator-associated pneumonia, severe hypoxemia.
	49 M	LMWH (enoxaparin)	LMWH	N/A	Death	Necrotizing pneumonia
Salam et al	36 M	N/A	tPA , LMWH (enoxaparin)	NOAC (Apixaban)	Recovery or discharge	N/A
Sethi et al	44 M	N/A	tPA, LMWH (enoxaparin), VA -ECMO	LMWH	Recovery or discharge	Bleeding within the oropharynx
Singh et al	69 F	N/A	IV heparin	NOAC (Rivaroxaban) with low dose ASA	Recovery or discharge	N/A
	33 M	N/A	IV heparin	NOAC (Rivaroxaban)	Recovery or discharge	N/A
	69 F	NOAC (Apixaban)	LMWH	N/A	Undetermined	Massive stroke in the territory of the left middle cerebral artery and clinically deteriorated.
Uppuluri et al	32 M	N/A	LMWH (enoxaparin)	NOAC (Apixaban)	Undetermined	N/A

VTE: venous thromboembolism, N/A: not available, M: male, F: female, LMWH: low molecular weight heparin, IV: intravenous; NOAC: novel oral anticoagulants, VA-ECMO: venoarterial extracorporeal membrane oxygenation, AKI: acute kidney injury, tPA: tissue plasminogen activator, ASA: acetylsalicylic acid (aspirin)